Streamlining Care for Patients With Compression Neuropathies: The Carpal Tunnel Plus Pathway
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway).
- Who it may be relevant to
- Registry conditions: Carpal Tunnel Syndrome (CTS). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this clinical trial is to assess the impact of a new care pathway (the Carpal Tunnel Plus Pathway) in patients with carpal tunnel syndrome. The main questions it aims to answer are: 1. What was the effect of the Carpal Tunnel Plus Pathway on wait times between each step of the care pathway (e.g. from referral to initial consult, from initial consult to surgical consult, etc.)? 2. How satisfied are patients with the care they received through the Carpal Tunnel Plus Pathway? Researchers will compare wait times pre- and post- Pathway implementation to see if there was any change. Participants will be asked to complete a short patient satisfaction survey.
Interventions
- Procedure Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)
Changes to the care pathway for carpal tunnel syndrome. Features of the CTS+ pathway include new referral form, care map for mild, moderate and severe CTS established, point or care ultrasound with steroid injection introduced, and expedited referral to surgeons.
Primary outcome measures
- Wait times [Time frame: From initial referral to surgery/injection (variable, but approximately 9 months)]
- Patient satisfaction [Time frame: Immediately after surgery/injection appointment]
Eligibility criteria
Inclusion criteria
- 18 years of age or older
- Referred to the Vancouver General Hospital Neuromuscular Disease Unit or St. Paul's Hospital with a confirmed diagnosis of carpal tunnel syndrome
- Ability to understand English
Exclusion criteria
- Inability to provide informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Canada · 1 center
- Vancouver General Hospital — Vancouver
Identifiers
NCT: NCT06717477 · H24-03066